Literature DB >> 8895091

Hemoglobin-dialdehyde dextran conjugates: improvement of their oxygen-binding properties with anionic groups.

F Bonneaux1, E Dellacherie, P Labrude, C Vigneron.   

Abstract

We studied the conjugates formed between hemoglobin and sulfated or unsulfated oxidized dextran. It appears that the presence of sulfated groups favors imino bond formation between the protein and the polymer, as the average molecular size of the conjugates is larger in this case. Under neutral conditions, the oxygen-binding properties of the conjugates depend on the presence or absence of oxygen during the coupling reaction. With unsulfated dextran, oxyhemoglobin leads to conjugates with increased oxygen affinity (P50/P50 native hemoglobin approximately 0.5) compared to that of free hemoglobin (P50 = 4 mm Hg), whereas deoxyhemoglobin leads to conjugates with decreased oxygen affinity (P50/P50 native hemoglobin approximately 3). The use of sulfated dextran reinforces this lowering in oxygen affinity, which indicates that sulfated dextran acts as a permanent macromolecular effector of hemoglobin (P50/P50 native hemoglobin approximately 4). Moreover, it can be assumed that some of the linkages involve the 2,3-diphosphoglycerate binding site, as the strong effector inositol hexaphosphate has only a slight effect on the oxygen-binding properties of the conjugate prepared in the deoxy state (P50/P50 native hemoglobin close to 4.4 and 6, respectively, for unsulfated and sulfated conjugates). Although dextran substituted with benzenehexacarboxylic acid (BHC) leads to a low-oxygen-affinity conjugate when linked to oxyhemoglobin through amide bonds (P50/P50 native hemoglobin approximately 5), oxidized dextran modified with BHC leads, with oxyhemoglobin, to a conjugate whose oxygen affinity is close to that of free hemoglobin (P50/P50 native hemoglobin approximately 1.2).

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8895091     DOI: 10.1007/bf01886853

Source DB:  PubMed          Journal:  J Protein Chem        ISSN: 0277-8033


  16 in total

1.  Fixation of aldehydic dextrans onto human deoxyhemoglobin.

Authors:  D Klett; M Grandgeorge; E Dellacherie
Journal:  Biopolymers       Date:  1992-05       Impact factor: 2.505

2.  Spectrophotometric studies; the crystallographic and optical properties of the hemoglobin of man in comparison with those of other species.

Authors:  D L DRABKIN
Journal:  J Biol Chem       Date:  1946-08       Impact factor: 5.157

3.  Interaction of a macromolecular polyanion, dextran sulfate, with human hemoglobin.

Authors:  D Sacco; E Dellacherie
Journal:  FEBS Lett       Date:  1986-04-21       Impact factor: 4.124

Review 4.  Hemoglobin and free radicals: implications for the development of a safe blood substitute.

Authors:  A I Alayash; R E Cashon
Journal:  Mol Med Today       Date:  1995-06

5.  [Determination of hemoglobin affinity for oxygen].

Authors:  D Labie; V Bycková
Journal:  Nouv Rev Fr Hematol       Date:  1971 Jan-Feb

6.  Hemoglobin solutions coupled with polyethylene glycol 1900: preparation, purification, quality control and pharmacological trials by hemorrhagic shock.

Authors:  P Labrude; P Mouelle; P Menu; C Vigneron; E Dellacherie; M Leonard; J L Tayot
Journal:  Int J Artif Organs       Date:  1988-09       Impact factor: 1.595

Review 7.  The development and use of oxygen-carrying blood substitutes.

Authors:  R A Dracker
Journal:  Immunol Invest       Date:  1995 Jan-Feb       Impact factor: 3.657

Review 8.  Liposome-encapsulated hemoglobin: an oxygen-carrying fluid.

Authors:  R Rabinovici; A S Rudolph; F S Ligler; T L Yue; G Feuerstein
Journal:  Circ Shock       Date:  1990-09

9.  Production of human hemoglobin in transgenic swine: an approach to a blood substitute.

Authors:  J K O'Donnell; M J Martin; J S Logan; R Kumar
Journal:  Cancer Detect Prev       Date:  1993

10.  Evaluation of a stroma-free hemoglobin solution for use as a plasma expander.

Authors:  S F Rabiner; J R Helbert; H Lopas; L H Friedman
Journal:  J Exp Med       Date:  1967-12-01       Impact factor: 14.307

View more
  2 in total

1.  Fc-DIRECTED ANTIBODY CONJUGATION OF MAGNETIC NANOPARTICLES FOR ENHANCED MOLECULAR TARGETING.

Authors:  Robabeh Rezaeipoor; Renu John; Steven G Adie; Eric J Chaney; Marina Marjanovic; Amy L Oldenburg; Stephanie A Rinne; Stephen A Boppart
Journal:  J Innov Opt Health Sci       Date:  2009-10-01

2.  In vivo magnetomotive optical molecular imaging using targeted magnetic nanoprobes.

Authors:  Renu John; Robabeh Rezaeipoor; Steven G Adie; Eric J Chaney; Amy L Oldenburg; Marina Marjanovic; Justin P Haldar; Bradley P Sutton; Stephen A Boppart
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-19       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.